Type to search

RQ Bio Launches with Goal to Transform Treatment and Prevention of Viral Infectious Diseases Through Antibody Technologies | Pharmtech Focus
LifeArc Co-founded Company RQ Bio Signs Licensing Agreement With AstraZeneca Worth Up to $157m Plus Royalties for Monoclonal Antibodies Against SARS-CoV-2 | Pharmtech Focus
Genetic Study Gives Extensive Insights into Severe Covid-19 | Pharmtech Focus